Is Perindopril registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 10 valid registrations of Perindopril, including COVERSYL 10MG F.C. TABLETS (10 mg, Film-coated tablet, SAR 45.45); COVERSYL 5MG F.C. TABLETS (5 mg, Film-coated tablet, SAR 34.55); Cenoril (10 mg, Film-coated tablet, SAR 36.90); Cenoril (5 mg, Film-coated tablet, SAR 28.05); PROVINDA (10 mg, Film-coated tablet, SAR 38.85).

Are there safety signals or safety updates for Perindopril?

EMA PRAC: 2 entries; US FDA: 1 entry (latest 2018-11-29).

Active substance

Perindopril

SFDA 10
NHS prices 3
Safety 3

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
COVERSYL 10MG F.C. TABLETS	10 mg	Film-coated tablet · Oral use	30 Bottle	SAR 45.45	NCE · Prescription	SERVIER	Valid
COVERSYL 5MG F.C. TABLETS	5 mg	Film-coated tablet · Oral use	30 Bottle	SAR 34.55	NCE · Prescription	SERVIER	Valid
Cenoril	10 mg	Film-coated tablet · Oral use	30 Blister	SAR 36.90	Generic · Prescription	Alrai Pharmaceutical industry Co. (L.L.C)	Valid
Cenoril	5 mg	Film-coated tablet · Oral use	30 Blister	SAR 28.05	Generic · Prescription	Alrai Pharmaceutical industry Co. (L.L.C)	Valid
PROVINDA	10 mg	Film-coated tablet · Oral use	30 Blister	SAR 38.85	Generic · Prescription	SPIMACO	Valid
PROVINDA	5 mg	Film-coated tablet · Oral use	30 Blister	SAR 29.55	Generic · Prescription	SPIMACO	Valid
Prestoprix	10 mg	Film-coated tablet · Oral use	30 Bottle	SAR 36.90	Generic · Prescription	Med City Pharma	Valid
Prestoprix	5 mg	Film-coated tablet · Oral use	30 Bottle	SAR 28.05	Generic · Prescription	Med City Pharma	Valid
TENORYL 10 MG film-coated tablet	10 mg	Film-coated tablet · Oral use	30 Bottle	SAR 40.90	Generic · Prescription	Tabuk Pharmaceutical Manufacturing Company	Valid
TENORYL 5 MG film-coated tablet	5 mg	Film-coated tablet · Oral use	30 Bottle	SAR 31.10	Generic · Prescription	Tabuk Pharmaceutical Manufacturing Company	Valid

Indications — CHI Daman Drug Formulary

CHRONIC KIDNEY DISEASE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; HYPERTENSION; SICKLE CELL DISEASE - ALBUMINURIA MANAGEMENT; SYSTEMIC LUPUS ERYTHEMATOSUS

Prices — United States and England

Source	Product as listed	Price	Unit / pack	Date
NHS Drug Tariff	Perindopril arginine 10mg tablets	£10.65	30 tablet	1 Oct 2026
NHS Drug Tariff	Perindopril arginine 2.5mg tablets	£4.43	30 tablet	1 Oct 2026
NHS Drug Tariff	Perindopril arginine 5mg tablets	£6.28	30 tablet	1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Safety signals and safety-related labeling changes

EMA PRAC 29 Nov 2018 PRAC signal: Raynaud’s phenomenon
Action for MAH: update of the product information: Yes
EMA PRAC 12 Jul 2018 PRAC signal: Raynaud’s phenomenon
Action for MAH: update of the product information: No
US FDA 29 Sep 2017 PRESTALIA — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Drug Interactions; Use in Specific Populations

All safety entries for perindopril →

Combinations containing Perindopril

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.